ABBV · XBRL financial data

AbbVie financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ABBV's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	45,804	56,197	58,054	54,318	56,334	61,160
Revenue from contracts with customers	45,804	56,197	58,054	54,318	56,334	61,160
Cost of goods and services sold	15,387	17,446	17,414	20,415	16,904	18,204
Selling, general and administrative	11,299	12,349	15,260	12,872	14,752	14,010
Other operating income (expense)	0	(432)	(56)	179	7	241
Operating income (loss)	11,363	17,924	18,117	12,757	9,137	15,075
Interest expense	2,454	2,423	2,230	2,224	2,808	2,893
Other income (expense)	(5,614)	(2,500)	(2,448)	(4,677)	(3,240)	(5,793)
Income tax expense (benefit)	(1,224)	1,440	1,632	1,377	(570)	2,364
Net income (loss)	4,616	11,542	11,836	4,863	4,278	4,226
Earnings per share, basic USD per share	2.73	6.48	6.65	2.73	2.40	2.37
Earnings per share, diluted USD per share	2.72	6.45	6.63	2.72	2.39	2.36
Weighted average shares, basic millions of shares	1,667	1,770	1,771	1,768	1,769	1,769
Weighted average shares, diluted millions of shares	1,673	1,777	1,778	1,773	1,773	1,773

Fiscal years (ABBV's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	8,449	9,746	9,201	12,814	5,524	5,229
Short-term investments	30	84	28	2	31	28
Accounts receivable	8,822	9,977	11,254	11,155	10,919	12,589
Inventory	3,310	3,128	3,579	4,099	4,181	4,951
Prepaid and other current assets	—	—	—	—	—	6,293
Total current assets	24,173	27,928	28,463	33,002	25,582	29,062
Property and equipment, net	5,248	5,110	4,935	4,989	5,134	5,628
Right-of-use asset	895	762	737	744	723	737
Goodwill	33,124	32,379	32,156	32,293	34,956	35,640
Total assets	150,565	146,529	138,805	134,711	135,161	133,960
Accounts payable	2,276	2,882	2,934	3,688	2,945	3,592
Total current liabilities	28,661	35,194	29,538	37,841	38,749	43,289
Lease liability, non-current	832	713	754	735	697	689
Retained earnings (accumulated deficit)	1,055	3,127	4,784	(1,000)	(7,900)	(15,493)
Total stockholders' equity	13,076	15,408	17,254	10,360	3,325	(3,270)
Total liabilities and equity	150,565	146,529	138,805	134,711	135,161	133,960
Common shares outstanding (cover page) millions of shares	1,766	1,769	1,769	1,766	1,765	1,768

Fiscal years (ABBV's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	4,616	11,542	11,836	4,863	4,278	4,226
Stock-based compensation	753	692	671	747	911	955
Net cash from operating activities	17,588	22,777	24,943	22,839	18,806	19,030
Purchases of property and equipment	798	787	695	777	974	1,214
Net cash from investing activities	(37,557)	(2,344)	(623)	(2,009)	(20,820)	(6,643)
Share repurchases	978	934	1,487	1,972	1,708	980
Dividends paid	7,716	9,261	10,043	10,539	11,025	11,657
Proceeds from long-term debt	3,000	1,000	2,000	—	16,963	3,994
Net cash from financing activities	(11,501)	(19,039)	(24,803)	(17,222)	(5,211)	(12,724)
Net change in cash	(31,475)	1,297	(545)	3,613	(7,290)	(295)

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.